Literature DB >> 26784540

Pruning the ricket thicket.

Valentin David, Myles Wolf.   

Abstract

Overexpression of FGF23 results in hypophosphatemic rickets, which is characterized by renal phosphate wasting, inappropriately low circulating levels of the active form of vitamin D, and skeletal abnormalities. The precise mechanisms of how excess FGF23 leads to hypophosphatemic rickets are not clear. In this issue of the JCI, Bai and colleagues demonstrate that deletion or inhibition of CYP24A1, which initiates degradation of the active form of vitamin D, ameliorates skeletal abnormalities in two mouse models of hypophosphatemic rickets. While this work supports an important role for excess CYP24A1 activity in the pathogenesis of FGF23-mediated hypophosphatemic rickets, more work will need to be done before CYP24A1 inhibition can be integrated into the management of patients living with these diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26784540      PMCID: PMC4731155          DOI: 10.1172/JCI85005

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.

Authors:  Thomas O Carpenter; Erik A Imel; Mary D Ruppe; Thomas J Weber; Mark A Klausner; Margaret M Wooddell; Tetsuyoshi Kawakami; Takahiro Ito; Xiaoping Zhang; Jeffrey Humphrey; Karl L Insogna; Munro Peacock
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

2.  Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.

Authors:  D Zehnder; R Bland; M C Williams; R W McNinch; A J Howie; P M Stewart; M Hewison
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

3.  Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway.

Authors:  G S Reddy; K Y Tserng
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

4.  Metabolic pathways from 1 alpha,25-dihydroxyvitamin D3 to 1 alpha,25-dihydroxyvitamin D3-26,23-lactone. Stereo-retained and stereo-selective lactonization.

Authors:  S Ishizuka; A W Norman
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

5.  CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.

Authors:  Xiuying Bai; Dengshun Miao; Sophia Xiao; Dinghong Qiu; René St-Arnaud; Martin Petkovich; Ajay Gupta; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

6.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Structural characterization of the gene encoding rat 25-hydroxyvitamin D3 24-hydroxylase.

Authors:  Y Ohyama; M Noshiro; G Eggertsen; O Gotoh; Y Kato; I Björkhem; K Okuda
Journal:  Biochemistry       Date:  1993-01-12       Impact factor: 3.162

8.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

Authors:  Takashi Shimada; Makoto Kakitani; Yuji Yamazaki; Hisashi Hasegawa; Yasuhiro Takeuchi; Toshiro Fujita; Seiji Fukumoto; Kazuma Tomizuka; Takeyoshi Yamashita
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

9.  1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells.

Authors:  S Ishizuka; N Kurihara; S Hakeda; N Maeda; K Ikeda; M Kumegawa; A W Norman
Journal:  Endocrinology       Date:  1988-08       Impact factor: 4.736

10.  X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization.

Authors:  T Costa; P J Marie; C R Scriver; D E Cole; T M Reade; B Nogrady; F H Glorieux; E E Delvin
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.